2D Healthcare
2D Healthcare
I-Cell Networks · Japan
Quel traitement pour quelle tumeur ?
Guide du diagnostic

Lymphoma

In lymphoma, chemotherapy and immunotherapy are strong standards; for refractory/relapsed B-cell lymphomas, CAR-T cell therapy is a licensed and established option in Japan.

À savoir sur ce diagnostic

  • CAR-T is a cell therapy with demonstrated efficacy in relapsed B-cell lymphoma.

  • iPSC-derived 'off-the-shelf' cell programs (iCART) are an investigational approach aiming to shorten waiting time.

  • Evaluation is based on lymphoma subtype and prior treatment responses.

Note importante

Lymphoma subtypes behave very differently; your file is reviewed by the hematology expert board.

2D Healthcare
2D Healthcare

Votre porte vers les thérapies avancées du Japon.

info@2dhealthcare.com
+90 538 541 11 02 · +90 531 670 24 60
Küçük Çamlıca Mah. Vefakar Sok. No:1, 34696 Üsküdar / İstanbul
Retrouvez-nous sur Google MapsLinkedIn

2D Healthcare ne fournit ni diagnostic ni traitement médical ; uniquement des services de coordination. Toutes les décisions médicales relèvent de médecins agréés au Japon.

© 2026 2D Healthcare · Tous droits réservés.

2D Healthcare — a Diagenics Ar-Ge Ltd. Şti. company